Detailed information for compound 1426005

Basic information

Technical information
  • TDR Targets ID: 1426005
  • Name: N-ethyl-1,3,3-trimethyl-2-oxo-N-phenylindole- 5-sulfonamide
  • MW: 358.455 | Formula: C19H22N2O3S
  • H donors: 0 H acceptors: 3 LogP: 2.96 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(S(=O)(=O)c1ccc2c(c1)C(C)(C)C(=O)N2C)c1ccccc1
  • InChi: 1S/C19H22N2O3S/c1-5-21(14-9-7-6-8-10-14)25(23,24)15-11-12-17-16(13-15)19(2,3)18(22)20(17)4/h6-13H,5H2,1-4H3
  • InChiKey: XPJIHOIUVCCNIX-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-ethyl-1,3,3-trimethyl-2-oxo-N-phenyl-indoline-5-sulfonamide
  • N-ethyl-1,3,3-trimethyl-2-oxo-N-phenyl-5-indolinesulfonamide
  • N-ethyl-2-keto-1,3,3-trimethyl-N-phenyl-indoline-5-sulfonamide
  • N-ethyl-1,3,3-trimethyl-2-oxo-N-phenyl-indole-5-sulfonamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Mus musculus RAR-related orphan receptor gamma Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus multilocularis Aminotransferase class III 0.0048 0.0896 0.5
Chlamydia trachomatis glutamate-1-semialdehyde-2,1-aminomutase 0.0048 0.0896 0.5
Wolbachia endosymbiont of Brugia malayi acetylornithine transaminase protein 0.0048 0.0896 0.5
Mycobacterium tuberculosis Adenosylmethionine-8-amino-7-oxononanoate aminotransferase BioA 0.034 1 1
Brugia malayi 4-aminobutyrate aminotransferase, mitochondrial precursor 0.0048 0.0896 1
Plasmodium falciparum ornithine aminotransferase 0.0048 0.0896 1
Echinococcus multilocularis ornithine aminotransferase 0.0048 0.0896 0.5
Echinococcus granulosus ornithine aminotransferase 0.0048 0.0896 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0336 0.5
Mycobacterium ulcerans adenosylmethionine-8-amino-7-oxononanoate aminotransferase 0.034 1 1
Trypanosoma brucei PAB1-binding protein , putative 0.003 0.0336 0.5
Mycobacterium ulcerans hypothetical protein 0.034 1 1
Plasmodium vivax ornithine aminotransferase, putative 0.0048 0.0896 1
Leishmania major hypothetical protein, conserved 0.003 0.0336 0.5
Trichomonas vaginalis acetylornithine aminotransferase, putative 0.034 1 0.5
Mycobacterium tuberculosis Probable aminotransferase 0.034 1 1
Schistosoma mansoni ornithine--oxo-acid transaminase 0.0048 0.0896 0.5
Trypanosoma cruzi PAB1-binding protein , putative 0.003 0.0336 0.5
Echinococcus granulosus Aminotransferase class III 0.0048 0.0896 0.5
Loa Loa (eye worm) hypothetical protein 0.003 0.0336 0.5
Echinococcus multilocularis ornithine aminotransferase 0.0048 0.0896 0.5
Toxoplasma gondii ornithine aminotransferase, mitochondrial precursor, putative 0.0048 0.0896 1
Brugia malayi hypothetical protein 0.003 0.0336 0.3753

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.1122 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 7.9433 um PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.